This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
In 2014, Edwards Lifescience launched an ambitious philanthropic initiative called Every Heartbeat Matters (EHM) with the goal of impacting the global burden of heart valve disease through the education, screening and treatment of 1 million underserved people by 2020. By enlisting the help of over 60 patient- and cardiac-focused non-profit partners through grant and product donation support, that goal was exceeded to affect more than 1.7 million underserved people in 46 countries, including 8,700 hearts treated and 164,900 hearts screened by humanitarian care. Additionally, more than 38,000 clinicians have received education to elevate heart valve care for underserved patients.
This month Edwards announced the expansion of that initiative with a new target to affect 2.5 million additional underserved structural heart and critical care patients by the end of 2025. This effort will broaden the initiative's focus from heart valve disease to all structural heart diseases and critical care support with an additional emphasis on recovery strategies, critical care development, and enhanced product donation.